The Gross Margin of Xeris Biopharma Holdings Inc (XERS) is 81.86%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 81.86% |
| 2023-12-31 | 82.52% |
| 2022-12-31 | 79.49% |
| 2021-12-31 | 73.19% |
| 2020-12-31 | 54.41% |
| 2019-12-31 | 40.74% |
| 2018-12-31 | 96.00% |
| 2017-12-31 | 100.00% |
| 2016-12-31 | 100.00% |